Aller au contenu principal
Profil bibliographique

Минара Шамхаловна Шамхалова

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

238Publications signalées
3431Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes and associated disordersLegal and Regulatory AnalysisLinguistic, Cultural, and Literary Studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Resolution of the Joint Meeting of the Expert Council "Hypoparathyroidism in the Era of Complex Problems and Breakthrough Technologies"

Н. Г. Мокрышева, Т. П. Бардымова, Е. Е. Бибик, Anna Eremkina et autres

On March 25, 2026, a meeting of the Expert Council entitled "Hypoparathyroidism in the Era of Complex Challenges and Breakthrough Technologies" was held in Moscow at the Endocrinology Research Centre. The meeting focused on the epidemiology of chronic hypoparathyroidism (hypoPT) in Russia, …

ru, us (code pays fourni par la source)

0 citations Problems of Endocrinology
Accès ouvert 2026 article OpenAlex

Sarcopenia in postmenopausal patients with type 1 diabetes mellitus: characteristics of functional, laboratory, and instrumental indicators

Antonina Pushkareva, Zhanna Belaya, Минара Шамхаловна Шамхалова, N. V. Shulpekova et autres

BACKGROUND . Patients with type 1 diabetes mellitus (T1DM) are prone to earlier development of sarcopenia due to insulin deficiency, hyperglycemia, oxidative stress, and mitochondrial dysfunction. A pressing challenge in the management of these patients is the search for standardized diagnostic tools …

ru (code pays fourni par la source)

0 citations Diabetes Mellitus
Accès ouvert 2025 article OpenAlex

Repeat kidney transplantation in a patient with type 1 diabetes mellitus and chronic pyelonephritis: a clinical case

A. N. Zvyagintseva, Daria V. Ivanova, А. С. Северина, Минара Шамхаловна Шамхалова

Cadaveric kidney allotransplantation remains the most effective and safest therapeutic option for end-stage renal disease in patients with diabetes mellitus. Successful graft survival requires consideration of multiple factors that may contribute to transplant injury. Particular emphasis should be placed on minimizing the …

ru (code pays fourni par la source)

0 citations Diabetes Mellitus
Accès ouvert 2025 article OpenAlex

Cardiovascular risk and chronic kidney disease: strategies for cardiac and renal protection. Interdisciplinary consensus

О. М. Драпкина, Zhanna Kobalava, М. В. Шестакова, Irina Bobkova et autres

The consensus was developed by experts from the Russian Scientific Medical Society of Internal Medicine, the Russian Society for the Prevention of Noncommunicable Diseases, the National Nephrology Association, the Professional Nephrology Association, the Russian Society of Cardiology, the Russian Medical Society for …

us, Tunisie, ru (code pays fourni par la source)

11 citations CARDIOVASCULAR THERAPY AND PREVENTION
Accès ouvert 2025 article OpenAlex

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

Peter Rossing, George L. Bakris, Vlado Perkovic, Richard E. Pratley et autres

OBJECTIVE: In the Evaluate Renal Function With Semaglutide Once Weekly (FLOW) trial, semaglutide reduced the risk of major kidney and cardiovascular (CV) outcomes and all-cause mortality in people with type 2 diabetes (T2D) and chronic kidney disease (CKD). This prespecified analysis assessed …

dk, us, au, de, be, pk (code pays fourni par la source)

17 citations Diabetes Care
2025 article OpenAlex

1971-LB: Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD—Data from the FLOW Trial

JOHANNES F.E. MANN, KATHERINE R. TUTTLE, Richard E. Pratley, KENNETH W. MAHAFFEY et autres

Introduction and Objective: In FLOW, semaglutide reduced the risk of kidney, cardiovascular (CV), and mortality outcomes in people with type 2 diabetes (T2D) and chronic kidney disease (CKD). We now test how the benefit of semaglutide relates to baseline BMI and change …

dk (code pays fourni par la source)

4 citations Diabetes
Accès ouvert 2025 article OpenAlex

Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents

E. R. Radkevich, А. С. Северина, Минара Шамхаловна Шамхалова, М. В. Шестакова

Oncological diseases are one of the leading causes of mortality in the world. Despite the intensive search for new methods to increase the efficacy and safety of antineoplastic therapy and to reduce resistance to it by malignant tumors, treatment issues still remain …

ru (code pays fourni par la source)

1 citation Diabetes Mellitus
Accès ouvert 2025 article OpenAlex

Markers of inflammation, fibrosis, endothelial dysfunction, and podocytopathy in patients with long-term type 1 diabetes mellitus

Madina I. Yevloyeva, Margarita Arutyunova, L. V. Nikankina, A. I. Sleptsova et autres

BACKGROUND: A comprehensive assessment of biomarkers involved in the development of systemic inflammation in patients with long-term type 1 diabetes mellitus (T1D), accompanied by the development and progression of cardiac and renal pathology, may allow stratification of patients according to specific inflammatory …

ru (code pays fourni par la source)

0 citations Diabetes Mellitus
Accès ouvert 2025 book OpenAlex

Алгоритмы специализированной медицинской помощи больным сахарным диабетом

Н. Г. Мокрышева, E.N. Andreeva, О. Б. Безлепкина, Valentina Peterkova et autres

Данное издание содержит двенадцатый актуализированный выпуск рекомендаций по стандартизации и оптимизации оказания медицинской помощи пациентам с сахарным диабетом во всех регионах России на основе доказательной медицины. Включена обновленная информация в соответствии с результатами крупных завершенных клинических исследований и последними международными и отечественными …

sk (code pays fourni par la source)

6 citations
Accès ouvert 2025 article OpenAlex

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease

В. Т. Ивашкин, О. М. Драпкина, М. V. Maevskaya, K. L. Raikhelson et autres

Aim . The clinical guidelines are intended to provide information support for making decisions by gastroenterologists, general practitioners and internists that will improve the quality of medical care for patients with non-alcoholic fatty liver disease, taking into account the latest clinical data …

ru, us (code pays fourni par la source)

17 citations Russian Journal of Gastroenterology Hepatology Coloproctology
Accès ouvert 2025 article OpenAlex

Chronic kidney disease in patients with diabetes mellitus: new challenges

Минара Шамхаловна Шамхалова, O. Yu. Sukhareva, Sergey Andreevich Martynov, А. С. Северина et autres

Chronic kidney disease (CKD) is a supranosological concept, defined as a disorder of the structure and/or function of the kidneys for 3 months or more that leads to health consequences. CKD develops in 20–40% of patients with diabetes mellitus (DM). Dynamic analysis …

ru (code pays fourni par la source)

3 citations Diabetes Mellitus
Accès ouvert 2024 article OpenAlex

Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report

Madina I. Yevloyeva, Darya Savitskaya, А. С. Северина, Минара Шамхаловна Шамхалова et autres

Simultaneous pancreas and kidney transplantation the best way to restore normoglycemia and renal function in patients with type 1 diabetes mellitus and terminal chronic kidney disease. Pregnant patients after simultaneous pancreas and kidney transplantation are a high-risk group for adverse events/loss of …

ru (code pays fourni par la source)

0 citations Terapevticheskii arkhiv

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.